AMN HEALTHCARE SERVICES INC (AMN) Stock Fundamental Analysis
USA - NYSE:AMN - US0017441017 - Common Stock
21.17 USD
+1.21 (+6.06%)
20.77 USD
-0.4 (-1.89%)
AMN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. AMN has a medium profitability rating, but doesn't score so well on its financial health evaluation. AMN has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
AMN had positive earnings in the past year.
AMN had a positive operating cash flow in the past year.
Of the past 5 years AMN 4 years were profitable.
Each year in the past 5 years AMN had a positive operating cash flow.
1.2 Ratios
AMN has a Return On Assets of -13.46%. This is in the lower half of the industry: AMN underperforms 79.21% of its industry peers.
Looking at the Return On Equity, with a value of -49.02%, AMN is doing worse than 73.27% of the companies in the same industry.
AMN has a Return On Invested Capital (2.66%) which is comparable to the rest of the industry.
AMN had an Average Return On Invested Capital over the past 3 years of 13.14%. This is above the industry average of 9.28%.
The 3 year average ROIC (13.14%) for AMN is well above the current ROIC(2.66%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -13.46% | ||
| ROE | -49.02% | ||
| ROIC | 2.66% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
1.3 Margins
AMN has a Operating Margin (2.12%) which is in line with its industry peers.
AMN's Operating Margin has declined in the last couple of years.
AMN has a Gross Margin (29.84%) which is in line with its industry peers.
In the last couple of years the Gross Margin of AMN has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.12% | ||
| PM (TTM) | N/A | ||
| GM | 29.84% |
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AMN is still creating some value.
The number of shares outstanding for AMN has been increased compared to 1 year ago.
AMN has less shares outstanding than it did 5 years ago.
AMN has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.39 indicates that AMN is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.39, AMN perfoms like the industry average, outperforming 50.49% of the companies in the same industry.
AMN has a debt to FCF ratio of 3.59. This is a good value and a sign of high solvency as AMN would need 3.59 years to pay back of all of its debts.
AMN's Debt to FCF ratio of 3.59 is fine compared to the rest of the industry. AMN outperforms 74.26% of its industry peers.
A Debt/Equity ratio of 1.51 is on the high side and indicates that AMN has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.51, AMN is doing worse than 69.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.51 | ||
| Debt/FCF | 3.59 | ||
| Altman-Z | 2.39 |
ROIC/WACC0.35
WACC7.55%
2.3 Liquidity
A Current Ratio of 1.00 indicates that AMN may have some problems paying its short term obligations.
AMN has a worse Current ratio (1.00) than 72.28% of its industry peers.
AMN has a Quick Ratio of 1.00. This is a bad value and indicates that AMN is not financially healthy enough and could expect problems in meeting its short term obligations.
AMN's Quick ratio of 1.00 is on the low side compared to the rest of the industry. AMN is outperformed by 70.30% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
The earnings per share for AMN have decreased strongly by -59.73% in the last year.
The Earnings Per Share has been growing slightly by 0.80% on average over the past years.
Looking at the last year, AMN shows a very negative growth in Revenue. The Revenue has decreased by -14.33% in the last year.
The Revenue has been growing slightly by 6.07% on average over the past years.
EPS 1Y (TTM)-59.73%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-69.39%
Revenue 1Y (TTM)-14.33%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-11.14%
3.2 Future
AMN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.82% yearly.
The Revenue is expected to grow by 4.40% on average over the next years.
EPS Next Y-65.25%
EPS Next 2Y-43.85%
EPS Next 3Y-22.51%
EPS Next 5Y22.82%
Revenue Next Year-12.11%
Revenue Next 2Y-7.22%
Revenue Next 3Y-3.17%
Revenue Next 5Y4.4%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 10.03, the valuation of AMN can be described as reasonable.
Based on the Price/Earnings ratio, AMN is valued cheaply inside the industry as 92.08% of the companies are valued more expensively.
AMN is valuated cheaply when we compare the Price/Earnings ratio to 26.89, which is the current average of the S&P500 Index.
AMN is valuated rather expensively with a Price/Forward Earnings ratio of 20.28.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AMN indicates a somewhat cheap valuation: AMN is cheaper than 63.37% of the companies listed in the same industry.
AMN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.99, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.03 | ||
| Fwd PE | 20.28 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, AMN is valued cheaply inside the industry as 82.18% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AMN indicates a rather cheap valuation: AMN is cheaper than 99.01% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.18 | ||
| EV/EBITDA | 7.56 |
4.3 Compensation for Growth
AMN's earnings are expected to decrease with -22.51% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)12.47
EPS Next 2Y-43.85%
EPS Next 3Y-22.51%
5. Dividend
5.1 Amount
AMN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
21.17
+1.21 (+6.06%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners105.31%
Inst Owner Change0.14%
Ins Owners0.42%
Ins Owner Change0.71%
Market Cap811.23M
Revenue(TTM)2.77B
Net Income(TTM)-297838000
Analysts69.23
Price Target20.4 (-3.64%)
Short Float %6.23%
Short Ratio2.68
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)84.83%
Min EPS beat(2)53.64%
Max EPS beat(2)116.02%
EPS beat(4)4
Avg EPS beat(4)56.81%
Min EPS beat(4)5.34%
Max EPS beat(4)116.02%
EPS beat(8)8
Avg EPS beat(8)34.9%
EPS beat(12)12
Avg EPS beat(12)26.31%
EPS beat(16)16
Avg EPS beat(16)23.47%
Revenue beat(2)1
Avg Revenue beat(2)0.91%
Min Revenue beat(2)-0.06%
Max Revenue beat(2)1.88%
Revenue beat(4)3
Avg Revenue beat(4)1.99%
Min Revenue beat(4)-0.06%
Max Revenue beat(4)4.75%
Revenue beat(8)4
Avg Revenue beat(8)0.84%
Revenue beat(12)7
Avg Revenue beat(12)1.1%
Revenue beat(16)11
Avg Revenue beat(16)1.97%
PT rev (1m)0%
PT rev (3m)-24.63%
EPS NQ rev (1m)-3.03%
EPS NQ rev (3m)-12.09%
EPS NY rev (1m)-0.32%
EPS NY rev (3m)0.9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.09%
Revenue NY rev (1m)-0.19%
Revenue NY rev (3m)-2.32%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.03 | ||
| Fwd PE | 20.28 | ||
| P/S | 0.29 | ||
| P/FCF | 3.18 | ||
| P/OCF | 2.61 | ||
| P/B | 1.34 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.56 |
EPS(TTM)2.11
EY9.97%
EPS(NY)1.04
Fwd EY4.93%
FCF(TTM)6.67
FCFY31.49%
OCF(TTM)8.11
OCFY38.3%
SpS72.28
BVpS15.86
TBVpS-12.28
PEG (NY)N/A
PEG (5Y)12.47
Graham Number27.44
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -13.46% | ||
| ROE | -49.02% | ||
| ROCE | 3.58% | ||
| ROIC | 2.66% | ||
| ROICexc | 2.73% | ||
| ROICexgc | 8.39% | ||
| OM | 2.12% | ||
| PM (TTM) | N/A | ||
| GM | 29.84% | ||
| FCFM | 9.22% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
ROICexc(3y)13.46%
ROICexc(5y)13.47%
ROICexgc(3y)46.83%
ROICexgc(5y)47.63%
ROCE(3y)17.73%
ROCE(5y)17.46%
ROICexgc growth 3Y-38.44%
ROICexgc growth 5Y-11.09%
ROICexc growth 3Y-36.92%
ROICexc growth 5Y-11.74%
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
F-Score4
Asset Turnover1.25
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.51 | ||
| Debt/FCF | 3.59 | ||
| Debt/EBITDA | 4.11 | ||
| Cap/Depr | 33.64% | ||
| Cap/Sales | 1.99% | ||
| Interest Coverage | 1.13 | ||
| Cash Conversion | 139.35% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 2.39 |
F-Score4
WACC7.55%
ROIC/WACC0.35
Cap/Depr(3y)57.01%
Cap/Depr(5y)52.87%
Cap/Sales(3y)2.35%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-59.73%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-69.39%
EPS Next Y-65.25%
EPS Next 2Y-43.85%
EPS Next 3Y-22.51%
EPS Next 5Y22.82%
Revenue 1Y (TTM)-14.33%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-11.14%
Revenue Next Year-12.11%
Revenue Next 2Y-7.22%
Revenue Next 3Y-3.17%
Revenue Next 5Y4.4%
EBIT growth 1Y-70.44%
EBIT growth 3Y-38.24%
EBIT growth 5Y-7.5%
EBIT Next Year92.53%
EBIT Next 3Y25.77%
EBIT Next 5YN/A
FCF growth 1Y-32.27%
FCF growth 3Y-1.64%
FCF growth 5Y4.92%
OCF growth 1Y-33.9%
OCF growth 3Y1.61%
OCF growth 5Y7.34%
AMN HEALTHCARE SERVICES INC / AMN FAQ
What is the fundamental rating for AMN stock?
ChartMill assigns a fundamental rating of 4 / 10 to AMN.
What is the valuation status of AMN HEALTHCARE SERVICES INC (AMN) stock?
ChartMill assigns a valuation rating of 5 / 10 to AMN HEALTHCARE SERVICES INC (AMN). This can be considered as Fairly Valued.
How profitable is AMN HEALTHCARE SERVICES INC (AMN) stock?
AMN HEALTHCARE SERVICES INC (AMN) has a profitability rating of 4 / 10.
How financially healthy is AMN HEALTHCARE SERVICES INC?
The financial health rating of AMN HEALTHCARE SERVICES INC (AMN) is 3 / 10.